Technology implementation risk providers

Currently, physicians and patients determine the demand for pharmaceuticals and employers and insurers assume the risk and cost. As the price of new health care technologies escalates, payers will design and implement strategies to share risk and cost. Defined employer contributions, increased patient cost sharing, and benefit exclusions will be used to help control utilization and cost. In this environment, value-based assessments will be crucial to the adoption of any technological innovation. It is reasonable to expect public and private coverage for new therapies if evidence is provided regarding the costs and consequences of treatment. However, social and ethical dilemmas will certainly arise as therapies whose costs exceed their benefits are debated in the public arena. 

Another important activity is the process to evaluate new security technologies and their integration with computer systems. The procedural controls implemented as a result of a risk analysis provide a starting point to look for technologies that can replace procedural controls. These procedural controls are the result of security-related implementation requirements identified during the risk analysis. 

A risk-based waste classification system must focus on the inherent characteristics of waste, representative facilities, and generic events, because the system necessarily presumes that specific disposal sites and related waste treatment and disposal technologies have not yet been identified and characterized. NCRP emphasizes that the principles, framework, and implementation details of a risk-based waste classification system do not provide a substitute for site-specific risk assessments. The two most important cases where site-specific risk must be estimated are (1) an assessment of risk for the spectrum of actual wastes at a specific disposal site for the purpose of establishing site-specific waste acceptance criteria, and (2) an assessment of risk posed by a prior waste disposal at a site for the purpose of determining whether the risk is unacceptable and, thus, whether remedial action is required at the site. 

Abstract. In the past, many remedies implemented at contaminated sites have failed to achieve site remedial action objectives either because not all of the objectives were defined prior to selecting the remedy, or a remedy was selected that was not capable of achieving the site objectives. In order to ensure the selection of effective remedies, this report outline a process for i) the identification of risk-based and non-risk remedial action objectives and ii) the evaluation of potential technologies to identify an acceptable remedy that will achieve all of the site remedial action objectives. By providing for the separation of risk-based and non-risk remedial action objectives, the remedy selection process allows the user to both i) identify a range of remedies that are capable of protecting human health and ecological resources and ii) understand the additional constraints imposed by the non-risk objectives. 

This site provides free resources—in pdf format—on assessing and exploring three key areas in patient safety strategic planning, risk assessment, and determining readiness to prepare implementation of bar coding technology. 

---